Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01144741Terminated

Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome

Role: lead

NCT01306994Withdrawn

Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related Conditions

Role: lead

NCT01307475Terminated

Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions

Role: lead

NCT02532725Completed

Work-Related Effects of Heat, Activity, and Fat in Middle Aged Men

Role: lead

All 4 trials loaded